22 results
8-K
EX-99.2
VANI
Vivani Medical Inc
11 Apr 19
Regulation FD Disclosure
8:16am
at time of implant Gender Reason for Vision Loss Implant Duration as of 4/1/19 (months) UCLA S1 01/30/2018 56 Male Optic neuropathy secondary to severe
8-K
EX-10.1
VANI
Vivani Medical Inc
1 May 18
Departure of Directors or Certain Officers
6:30am
12900et seq. (which prohibits discrimination based on protected characteristics including race, color, religious creed, sex, gender, gender identity, gender
8-K
EX-99.2
VANI
Vivani Medical Inc
25 Jun 19
Researchers Present Latest Positive Results of Second Sight’s Orion Visual Cortical Prosthesis Feasibility Study
4:00pm
of Medicine
Site Subject Implant Date Age at time of implant Gender Reason for Vision Loss Implant Duration as of 6/28/19 (months) UCLA S1 01/30/2018
8-K
EX-99.3
VANI
Vivani Medical Inc
11 Apr 19
Regulation FD Disclosure
8:16am
of implant Gender Reason for Vision Loss* Implant Duration as of 4/1/19 (months) UCLA S1 01/30/2018 56 Male Optic neuropathy following severe burn/trauma
8-K
EX-99
68urvwgm9 m0
25 Jul 16
Second Sight Announces Positive Five-Year Data from Argus II Retinal Prosthesis System
12:00am
DEFR14A
l6f aaieil414
1 May 23
Revised proxy
4:49pm
8-K
EX-2.1
6yk5v3ko
6 Jan 21
Pixium Vision and Second Sight Medical Products announce business combination, creating a global leader in the sight restoration market
6:14am
DEFA14A
EX-2.1
xb7 o2arsii3hb4vznc7
6 Jan 21
Additional proxy soliciting materials
6:12am
425
EX-2.1
b56nml91xgh nl
8 Feb 22
Business combination disclosure
12:00am
8-K
EX-2.1
uo6pcxopnlq6e7
8 Feb 22
Second Sight Medical Products and Nano Precision Medical Announce Merger Agreement to Create Leading Therapeutic Implant Company
12:00am
424B3
u2o u7ge1dsc9p7dt
24 Jun 22
Prospectus supplement
4:38pm
DEFM14A
5gd0 qtxgbmm
24 Jun 22
Proxy related to merger
4:44pm